HOXC8 and non-small cell lung carcinoma: From the three MSC‐specific HOX candidates, HOXC8 was also found to be upregulated in clinical NSCLC specimens, and the high expression of HOXC8 correlated with tumor grade, tumor node metastasis stage, and poor relapse‐free survival for lung cancer patients.64